|
1.
|
Lohmann DR and Gallie BL: Retinoblastoma:
revisiting the model prototype of inherited cancer. Am J Med Genet
C Semin Med Genet. 129C:23–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gatta G, Capocaccia R, Stiller C, Kaatsch
P, Berrino F and Terenziani M; EUROCARE Working Group: Childhood
cancer survival trends in Europe: a EUROCARE Working Group study. J
Clin Oncol. 23:3742–3751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Abramson DH, Beaverson K, Sangani P, et
al: Screening for retinoblastoma: presenting signs as
prognosticators of patient and ocular survival. Pediatrics.
112:1248–1255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Balmer A, Zografos L and Munier F:
Diagnosis and current management of retinoblastoma. Oncogene.
25:5341–5349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Sun A, Bagella L, Tutton S, Romano G and
Giordano A: From G0 to S phase: a view of the roles played by the
retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell
Biochem. 102:1400–1404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Sabado Alvarez C: Molecular biology of
retinoblastoma. Clin Transl Oncol. 10:389–394. 2008.
|
|
7.
|
Jia RB, Zhang P, Zhou YX, et al:
VEGF-targeted RNA interference suppresses angiogenesis and tumor
growth of retinoblastoma. Ophthalmic Res. 39:108–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Chevez-Barrios P, Chintagumpala M, Mieler
W, et al: Response of retinoblastoma with vitreous tumor seeding to
adenovirus-mediated delivery of thymidine kinase followed by
ganciclovir. J Clin Oncol. 23:7927–7935. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kirn D, Martuza RL and Zwiebel J:
Replication-selective virotherapy for cancer: Biological
principles, risk management and future directions. Nat Med.
7:781–787. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kruyt FA and Curiel DT: Toward a new
generation of conditionally replicating adenoviruses: pairing tumor
selectivity with maximal oncolysis. Hum Gene Ther. 13:485–495.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ramachandra M, Rahman A, Zou A, et al:
Re-engineering adenovirus regulatory pathways to enhance oncolytic
specificity and efficacy. Nat Biotechnol. 19:1035–1041. 2001.
View Article : Google Scholar
|
|
12.
|
Fuerer C and Iggo R: Adenoviruses with Tcf
binding sites in multiple early promoters show enhanced selectivity
for tumour cells with constitutive activation of the wnt signalling
pathway. Gene Ther. 9:270–281. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Strauss M, Lukas J and Bartek J:
Unrestricted cell cycling and cancer. Nat Med. 1:1245–1246. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lu K, Shih C and Teicher BA: Expression of
pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor
lines in cell culture and in xenograft tissues and response to cell
cycle agents. Cancer Chemother Pharmacol. 46:293–304. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Jakubczak JL, Ryan P, Gorziglia M, et al:
An oncolytic adenovirus selective for retinoblastoma tumor
suppressor protein pathway-defective tumors: dependence on E1A, the
E2F-1 promoter, and viral replication for selectivity and efficacy.
Cancer Res. 63:1490–1499. 2003.
|
|
17.
|
Ries SJ and Brandts CH: Oncolytic viruses
for the treatment of cancer: current strategies and clinical
trials. Drug Discov Today. 9:759–768. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lowe SW, Ruley HE, Jacks T and Housman DE:
p53-dependent apoptosis modulates the cytotoxicity of anticancer
agents. Cell. 74:957–967. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Querido E, Marcellus RC, Lai A, et al:
Regulation of p53 levels by the E1B 55-kilodalton protein and
E4orf6 in adenovirus-infected cells. J Virol. 71:3788–3798.
1997.PubMed/NCBI
|
|
20.
|
Steegenga WT, Riteco N, Jochemsen AG,
Fallaux FJ and Bos JL: The large E1B protein together with the
E4orf6 protein target p53 for active degradation in adenovirus
infected cells. Oncogene. 16:349–357. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Cuconati A, Degenhardt K, Sundararajan R,
Anschel A and White E: Bak and Bax function to limit adenovirus
replication through apoptosis induction. J Virol. 76:4547–4558.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Farrow SN, White JH, Martinou I, et al:
Cloning of a bcl-2 homologue by interaction with adenovirus E1B
19K. Nature. 374:731–733. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hobom U and Dobbelstein M:
E1B-55-kilodalton protein is not required to block p53-induced
transcription during adenovirus infection. J Virol. 78:7685–7697.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Rao XM, Tseng MT, Zheng X, et al:
E1A-induced apoptosis does not prevent replication of adenoviruses
with deletion of E1b in majority of infected cancer cells. Cancer
Gene Ther. 11:585–593. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Rao XM, Zheng X, Waigel S, Zacharias W,
McMasters KM and Zhou HS: Gene expression profiles of normal human
lung cells affected by adenoviral E1B. Virology. 350:418–428. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Doloff JC, Waxman DJ and Jounaidi Y: Human
telomerase reverse transcriptase promoter-driven oncolytic
adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions. Hum Gene
Ther. 19:1383–1400. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ji X, Zhang J, Cheng L, et al: Oncolytic
adenovirus delivering herpes simplex virus thymidine kinase suicide
gene reduces the growth of human retinoblastoma in an in vivo mouse
model. Exp Eye Res. 89:193–199. 2009. View Article : Google Scholar
|
|
28.
|
Xu H, Wang C, Zhu H, Liu S, Xu X and Jiang
Y: Characteristics of an established retinoblastoma cell line
HXO-Rb44. Yan Ke Xue Bao. 11:16–21. 1995.
|
|
29.
|
White E: Regulation of the cell cycle and
apoptosis by the oncogenes of adenovirus. Oncogene. 20:7836–7846.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Subramanian T, Vijayalingam S and
Chinnadurai G: Genetic identification of adenovirus type 5 genes
that influence viral spread. J Virol. 80:2000–2012. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
White E: Mechanisms of apoptosis
regulation by viral oncogenes in infection and tumorigenesis. Cell
Death Differ. 13:1371–1377. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Cross JR, Postigo A, Blight K and Downward
J: Viral pro-survival proteins block separate stages in Bax
activation but changes in mitochondrial ultrastructure still occur.
Cell Death Differ. 15:997–1008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Yoon AR, Kim JH, Lee YS, et al: Markedly
enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in
combination with cisplatin. Hum Gene Ther. 17:379–390. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lomonosova E, Subramanian T and
Chinnadurai G: Mitochondrial localization of p53 during adenovirus
infection and regulation of its activity by E1B-19K. Oncogene.
24:6796–6808. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Matsushita T, Okada T, Inaba T, Mizukami
H, Ozawa K and Colosi P: The adenovirus E1A and E1B19K genes
provide a helper function for transfection-based adeno-associated
virus vector production. J Gen Virol. 85:2209–2214. 2004.
View Article : Google Scholar
|
|
36.
|
Polster BM, Pevsner J and Hardwick JM:
Viral Bcl-2 homologs and their role in virus replication and
associated diseases. Biochim Biophys Acta. 1644:211–227. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Tsukuda K, Wiewrodt R, Molnar-Kimber K,
Jovanovic VP and Amin KM: An E2F-responsive replication-selective
adenovirus targeted to the defective cell cycle in cancer cells:
potent anti-tumoral efficacy but no toxicity to normal cell. Cancer
Res. 62:3438–3447. 2002.PubMed/NCBI
|
|
38.
|
Rohmer S, Quirin C, Hesse A, et al:
Transgene expression by oncolytic adenoviruses is modulated by
E1B19K deletion in a cell type-dependent manner. Virology.
395:243–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
